Combined transfection of Bcl-2 siRNA and miR-15a oligonucleotides enhanced methotrexate-induced apoptosis in Raji cells

Cancer Biology and Medicine

Volumn 10, Issue 1, 2013, Pages 16-21

  Ding, Li ^a   Hu, Xiao Mao ^a   Wu, Hong ^a   Liu, Ge Xiu ^a   Gao, Yang Jun ^a   He, Dong Mei ^a   Zhang, Yuan ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Apoptosis; B cell lymphoma 2 (Bcl 2); Methotrexate; MiR 15a; Oligonucleotide; Raji cell; Small interfering RNA

Indexed keywords

METHOTREXATE; MICRORNA 15A; MICRORNA 15A OLIGONUCLEOTIDE; OLIGONUCLEOTIDE; PROTEIN BCL 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CHEMOLUMINESCENCE; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84877649531     PISSN: 20953941     EISSN: None     Source Type: Journal    
DOI: 10.7497/j.issn.2095-3941.2013.01.003     Document Type: Article

References (24)

1. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
2. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
3. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58-63.
4. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12.
5. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down- regulation of micro-RNA genes miR15 and miR16 at13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002; 99: 15524-15529.
6. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793-1801.
7. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944-13949.
8. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 2008; 105: 5166-5171.
9. Klasa RJ, Gillum AM, Klem RE, Frankel SR. Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment. Antisense Nucleic Acid Drug Dev 2002; 12: 193-213.
10. O'Neill J, Manion M, Schwartz P, Frankel SR. Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy. Biochim Biophys Acta 2004; 1705: 43-51.
11. Kirkin V, Joos S, Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 2004; 1644: 229-249.
12. Cioca DP, Aoki YJ, Kiyosawa K. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Therapy 2003; 10: 125-133.
13. He D, Fang B. Small hairpin RNA targeting at Bcl-2 increases cytarabine-induced apoptosis in Raji cells. Acta Biochim Biophys Sin 2009; 41: 131-136.
14. He D, Chen Q. Inhibition of the Growth of Raji Cells by Precursor MicroRNA-15a. Clin Oncol Cancer Res 2010; 7: 22-26.
15. Gao SM, Xing CY, Chen CQ, Lin SS, Dong PH, Yu FJ. miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level. J Exp Clin Cancer Res 2011; 30: 110.
16. Kim A, Lee JE, Jang WS, Lee SJ, Park S, Kang HJ, et al. A combination of methotrexate and irradiation promotes cell death in NK/T-cell lymphoma cells via down-regulation of NF-κB signaling. Leuk Res 2012; 36: 350-357.
17. Osada H, Takahashi T. MicroRNAs in biological processes and carcinogenesis. Carcinogenesis 2007; 28: 2-12.
18. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, et al. MiR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008; 123: 372-379.
19. Hu X, Li W, Liu G, Wu H, Gao Y, Chen S, et al. The effect of Bcl-2 siRNA combined with miR-15a oligonucleotides on the growth of Raji cells. Med Oncol 2013; 30: 430.
20. Biroccio A, Leonetti C, Zupi G. The future of antisense therapy: combination with anticancer treatments. Oncogene 2003; 22: 6579-6588.
21. Gao SM, Chen C, Wu J, Tan Y, Yu K, Xing CY, et al. Synergistic apoptosis induction in leukemic cells by miR-15a/16-1 and arsenic trioxide. Biochem Biophys Res Commun 2010; 403: 203-208.
22. Xing XK, Li SJ, He JL, Chen Z. Inhibition of hepatitis C virus replication by single and dual small interfering RNA using an HCV-infected cell model. Biotechnol Lett 2012; 34: 295-301.
23. Nagamatsu K, Tsuchiya F, Oguma K, Maruyama H, Kano R, Hasegawa A. The effect of small interfering RNA (siRNA) against the Bcl-2 gene on apoptosis and chemosensitivity in a canine mammary gland tumor cell line. Res Vet Sci 2008; 84: 49-55.
24. Lei XY, Zhong M, Feng LF, Zhu BY, Tang SS, Liao DF. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs. Clin Exp Pharmacol Physiol 2007; 34: 450-456.